top of page

Current Grants

Our research is made possible thanks to the following funding grants:

2016-2021         
A randomised placebo-controlled trial of immunotherapy in patients with psychosis associated with anti-neuronal membrane antibodies (SINAPPS 2). Medical Research Council. (£2,466,231 fEC) Coles with Co-PI: Peter Jones and Belinda Lennox. MRC Reference: MR/N019067/1

​

2020-2025         
A double-blind, randomised, placebo-controlled study of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy: a phase 2b trial. Cunniffe and Coles. Multiple Sclerosis Society (£565,113)

​

2020-2025           
Centre of Excellence Grant [Coles Co-PI with Ragnhildur Thora Karadottir] Combatting progression in MS – when and how?. Multiple Sclerosis Society (£1,850,000)

​

2022-

Using eye tracking as a novel biomarker of remyelination in people living with multiple sclerosis. Ferblanc. Cunniffe (£25,587)

​

2022-2025

Examining the long-term effects of the combination of metformin and clemastine on remyelination and neuroprotection; a follow-up study of the Cambridge Centre for Myelin Repair trial Two. Academy of Medical Sciences Starter Grant. Cunniffe. (£29,810)

​

2022-2027 
Improving the long-term outcomes for people with multiple sclerosis by studying real world data. National Institute for Health and Care Research (NIHR), (£1,428,113). Brown. NIHR ref 301728.

​

2023-2025

Using eye tracking as a novel biomarker of remyelination and neuroprotection in people living with multiple sclerosis. Evelyn Trust (reference number 23/08). Cunniffe. (£42,380)

 

2023-2026
Digital Transformation and Care. Brown (PI): all paid to Cambridge University Hospitals. (£905,000). Financial support provided by Roche, Sanofi and Novartis to pay for NHS-employed research assistants to ensure the safety, efficiency and research capabilities in THRIVE-MS are realised.

​​

2024-2025
Unravelling the genetic contributions to remyelination failure in people living with multiple sclerosis. Brain repair centre NIHR Pump Prime award. Cunniffe. (£18,423.64).

​

​

FOR PEOPLE WITH MS

bottom of page